Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients

PURPOSE: This prospective clinical trial investigated sodium ((23)Na) MRI at 7 Tesla (T) field strength as biomarker for tumor extent, isocitrate dehydrogenase (IDH) mutation and O6-methylguanine DNA methyltransferase (MGMT) promotor methylation in glioma patients. METHODS: 28 glioma patients underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Regnery, Sebastian, Behl, Nicolas G.R., Platt, Tanja, Weinfurtner, Nina, Windisch, Paul, Deike-Hofmann, Katerina, Sahm, Felix, Bendszus, Martin, Debus, Jürgen, Ladd, Mark E., Schlemmer, Heinz-Peter, Rieken, Stefan, Adeberg, Sebastian, Paech, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527584/
https://www.ncbi.nlm.nih.gov/pubmed/33002860
http://dx.doi.org/10.1016/j.nicl.2020.102427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527584/
https://www.ncbi.nlm.nih.gov/pubmed/33002860
http://dx.doi.org/10.1016/j.nicl.2020.102427

Ejemplares similares